Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $83.93 million. The enterprise value is $88.22 million.
Important Dates
The last earnings date was Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 8.51 million shares outstanding. The number of shares has increased by 52.43% in one year.
| Current Share Class | 8.51M |
| Shares Outstanding | 8.51M |
| Shares Change (YoY) | +52.43% |
| Shares Change (QoQ) | +3.38% |
| Owned by Insiders (%) | 2.31% |
| Owned by Institutions (%) | 27.85% |
| Float | 3.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.78 |
| Forward PS | 350.02 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.81 |
| EV / EBITDA | 11.53 |
| EV / EBIT | 12.09 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16
| Current Ratio | 2.16 |
| Quick Ratio | 1.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.70 |
| Debt / FCF | n/a |
| Interest Coverage | 2.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 11.12% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 50.86% |
| Weighted Average Cost of Capital (WACC) | 7.34% |
| Revenue Per Employee | $1.65M |
| Profits Per Employee | -$676,214 |
| Employee Count | 14 |
| Asset Turnover | 0.56 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATRA has paid $31,000 in taxes.
| Income Tax | 31,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.44% in the last 52 weeks. The beta is 0.11, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | +27.44% |
| 50-Day Moving Average | 6.66 |
| 200-Day Moving Average | 10.13 |
| Relative Strength Index (RSI) | 60.22 |
| Average Volume (20 Days) | 4,258,477 |
Short Selling Information
The latest short interest is 546,470, so 6.42% of the outstanding shares have been sold short.
| Short Interest | 546,470 |
| Short Previous Month | 306,093 |
| Short % of Shares Out | 6.42% |
| Short % of Float | 14.47% |
| Short Ratio (days to cover) | 0.15 |
Income Statement
In the last 12 months, ATRA had revenue of $23.14 million and -$9.47 million in losses. Loss per share was -$0.71.
| Revenue | 23.14M |
| Gross Profit | -2.70M |
| Operating Income | 7.30M |
| Pretax Income | -9.44M |
| Net Income | -9.47M |
| EBITDA | 7.65M |
| EBIT | 7.30M |
| Loss Per Share | -$0.71 |
Full Income StatementBalance Sheet
The company has $8.36 million in cash and $9.08 million in debt, with a net cash position of -$716,000 or -$0.08 per share.
| Cash & Cash Equivalents | 8.36M |
| Total Debt | 9.08M |
| Net Cash | -716,000 |
| Net Cash Per Share | -$0.08 |
| Equity (Book Value) | -37.31M |
| Book Value Per Share | -4.38 |
| Working Capital | 6.53M |
Full Balance SheetCash Flow
| Operating Cash Flow | -25.88M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 350,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -25.88M |
| FCF Per Share | -$3.04 |
Full Cash Flow StatementMargins
Gross margin is -11.66%, with operating and profit margins of 31.55% and -40.91%.
| Gross Margin | -11.66% |
| Operating Margin | 31.55% |
| Pretax Margin | -40.78% |
| Profit Margin | -40.91% |
| EBITDA Margin | 33.06% |
| EBIT Margin | 31.55% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -52.43% |
| Shareholder Yield | -52.43% |
| Earnings Yield | -10.82% |
| FCF Yield | -29.57% |
Analyst Forecast
The average price target for ATRA is $13.67, which is 38.64% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.67 |
| Price Target Difference | 38.64% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -29.64% |
| EPS Growth Forecast (3Y) | -37.75% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
